Interestingly, our study also revealed that ZDHHC19 is upregulated in various cancer types, including bladder and breast cancer, which aligns with previous research demonstrating its role in tumor progression and modulation of the immune microenvironment. Here, ZDHHC19 is linked to neoplasm.